Plasma Fibroblast Growth Factor 23, Parathyroid Hormone, 25-Hydroxyvitamin D3, and Risk of Heart Failure: A Prospective, Case-Cohort Study | Zendy

Romina di Giuseppe | Zendy; Brian Buijsse | Zendy; Frank Hirche | Zendy; Janine Wirth | Zendy; María Arregui | Zendy; Sabine Westphal | Zendy; Berend Isermann | Zendy; Hans W. Hense | Zendy; Jutta Dierkes | Zendy; Heiner Boeing | Zendy; Gabriele I. Stangl | Zendy; Cornelia Weikert | Zendy

Open Access

Plasma Fibroblast Growth Factor 23, Parathyroid Hormone, 25-Hydroxyvitamin D3, and Risk of Heart Failure: A Prospective, Case-Cohort Study

Author(s) -

Romina di Giuseppe,

Brian Buijsse,

Frank Hirche,

Janine Wirth,

María Arregui,

Sabine Westphal,

Berend Isermann,

Hans W. Hense,

Jutta Dierkes,

Heiner Boeing,

Gabriele I. Stangl,

Cornelia Weikert

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2013-2963

Subject(s) - medicine , hazard ratio , prospective cohort study , vitamin d and neurology , population , parathyroid hormone , endocrinology , cohort , risk factor , heart failure , cohort study , fibroblast growth factor 23 , gastroenterology , confidence interval , calcium , environmental health

Bone mineral metabolism may play a role in the development of heart failure (HF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research